Use of aloe-emodin in the preparation of blood lipid-lowering and liver fat-lowering drugs
An aloe-emodin and medicine technology, which is applied in the field of medicine and achieves the effects of easy acceptance, strong medicinal properties and strong lipid-lowering effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] Embodiment 1 aloe-emodin acute toxicity test
[0029] 1 Experimental method:
[0030] The acute toxicity of aloe-emodin was evaluated by the maximum tolerated dose method. The specific method is as follows: 40 mice were randomly divided into a control group and an experimental group, with 20 mice in each group, half male and half male. Aloe-emodin is prepared into a 0.5g / mL suspension with 1% (quality of Tween-80 / volume of water) Tween-80 aqueous solution, and the experimental group is based on (50g aloe-emodin) / (kg mouse body weight) The dose was given to the mice by intragastric administration, and the administration was divided into 3 times in 1 day, each time interval was 3h. The mice were administrated with 10 mL / kg of 0.5 g / mL aloe-emodin suspension for the first time. At the same time, mice in the control group were intragastrically administered 1% Tween-80 aqueous solution according to the same dosage regimen.
[0031] After administration, the mice were fed...
Embodiment 2
[0034] Example 2 Pharmacodynamic study of aloe-emodin hypolipidemic effect
[0035] 1 Experimental method:
[0036] 60 Wistar male rats were randomly divided into six groups: normal control group, high-fat model group, atorvastatin group (7.2mg atorvastatin / kg rat body weight, equivalent to the maximum clinical dose of human body), high-dose Aloe-emodin group (100mg aloe-emodin / kg rat body weight), medium-dose aloe-emodin group (50mg aloe-emodin / kg rat body weight) and low-dose aloe-emodin group (25mg aloe-emodin / kg rat body weight ), 10 in each group. The normal control group was fed with 20g / bird of common feed, and the rest of the groups were fed with 20g / high-fat feed for 4 weeks, with free drinking water, to establish a hyperlipidemia model.
[0037] Atorvastatin was formulated with 1% Tween-80 to prepare 0.72 mg / mL suspension, and aloe-emodin was prepared with 1% Tween-80 to prepare 10, 5 and 2.5 mg / mL suspensions, respectively. The atorvastatin group used atorvastati...
Embodiment 3
[0043] Example 3 Pharmacodynamic study of the effect of aloe-emodin on reducing liver fat
[0044] 1 Experimental method:
[0045] 60 Wistar male rats were randomly divided into six groups: normal control group, high-fat model group, atorvastatin group (7.2mg atorvastatin / kg rat body weight), high-dose aloe-emodin group (400mg aloe-rhubarb Aloe-emodin / kg rat body weight), middle dose aloe-emodin group (200mg aloe-emodin / kg rat body weight) and low-dose aloe-emodin group (100mg aloe-emodin / kg rat body weight), 10 rats in each group. The method for establishing the hyperlipidemia model is the same as in Example 2.
[0046] Atorvastatin was formulated with 1% Tween-80 to prepare 0.72 mg / mL suspension, and aloe-emodin was prepared with 1% Tween-80 to prepare 40, 20 and 10 mg / mL suspension respectively. In the atorvastatin group, atorvastatin suspension was administered to rats at a dose of 7.2 mg / kg, and in the high, middle, and low dose aloe-emodin groups, the doses of 400, 200...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com